cf33 oncolytic virus therapy
cf33 oncolytic virus therapy: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| RenovoRx, Inc. (RNXT) | Preclinical |
Get deeper analysis on cf33 oncolytic virus therapy
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis